share_log
Reuters ·  Nov 4 20:23
BioCryst Pharmaceuticals Shares Down 5.1% Premarket After Q3 Results
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment